Filing Details

Accession Number:
0001209191-19-050257
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-09-19 21:29:26
Reporting Period:
2019-09-18
Accepted Time:
2019-09-19 21:29:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1496323 Igm Biosciences Inc. IGMS Pharmaceutical Preparations (2834) 770349194
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1786442 Teng Christina Topsoe C/O Igm Biosciences, Inc.
325 E. Middlefield Road
Mountain View CA 94043
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-09-18 34,375 $16.00 34,375 No 4 P Direct
Common Stock Acquisiton 2019-09-18 1,250,000 $16.00 1,250,000 No 4 P Indirect See footnote
Common Stock Acquisiton 2019-09-20 9,039,453 $0.00 10,289,453 No 4 C Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect See footnote
No 4 C Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Preferred Stock Disposition 2019-09-20 9,039,453 $0.00 9,039,453 $0.00
Non-Voting Common Stock Series C Preferred Stock Disposition 2019-09-20 2,269,838 $0.00 2,269,838 $0.00
Common Stock Non-Voting Common Stock Acquisiton 2019-09-20 2,269,838 $0.00 2,269,838 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
2,269,838 No 4 C Indirect
Footnotes
  1. All shares are held directly by Haldor Topsoe Holding A/S (HTH). Mr. Jakob Haldor Topsoe, Ms. Christina Teng Topsoe, Mr. Martin Topsoe and Mr. Emil Oigaard, members of the board of directors of HTH, may be deemed to share voting and investment power with respect to the shares reported herein and disclaim beneficial ownership of such shares, except to the extent of his or her pecuniary interest therein, if any. Mr. Jakob Haldor Topsoe and Ms. Christina Teng Topsoe are members of the Issuer's board of directors.
  2. The Series B Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock has no expiration date.
  3. The Series C Preferred Stock automatically converted into shares of Non-Voting Common Stock on a 1-for-1 basis, pursuant to an election made by the Reporting Person, immediately prior to the closing of the Issuer's initial public offering, and has no expiration date. Each share of Non-Voting Common Stock is convertible at any time at the option of the Reporting Person into one share of Common Stock (subject to a 4.99% beneficial ownership limitation that may be increased or decreased by the Reporting Person) and has no expiration date.